1. SABR versus conventional fractionation regimens in NSCLC. Issue 5 (May 2019) Authors: Addeo, Alfredo; Buffoni, Lucio Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: e230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection. (September 2018) Authors: Banna, Giuseppe Luigi; Passiglia, Francesco; Colonese, Francesca; Canova, Stefania; Menis, Jessica; Addeo, Alfredo; Russo, Antonio; Cortinovis, Diego Luigi Journal: Critical reviews in oncology/hematology Issue: Volume 129(2018) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LUX-Lung 7: is there enough data for a final conclusion?. Issue 7 (July 2016) Authors: Di Maio, Massimo; Addeo, Alfredo Journal: Lancet oncology Issue: Volume 17:Issue 7(2016:Jul.) Page Start: e266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prophylactic cranial irradiation in extensive disease small cell lung cancer: An endless debate. (November 2019) Authors: Picardi, Cristina; Caparroti, Francesca; Di Maio, Massimo; Kaššák, Filip; Banna, Giuseppe Luigi; Addeo, Alfredo Journal: Critical reviews in oncology/hematology Issue: Volume 143(2019) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer. (3rd November 2020) Authors: Mederos, Nuria; Friedlaender, Alex; Peters, Solange; Addeo, Alfredo Journal: ESMO open Issue: Volume 5(2020)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer. (23rd June 2020) Authors: Passaro, Antonio; Addeo, Alfredo; Von Garnier, Christophe; Blackhall, Fiona; Planchard, David; Felip, Enriqueta; Dziadziuszko, Rafal; de Marinis, Filippo; Reck, Martin; Bouchaab, Hasna; Peters, Solange Journal: ESMO open Issue: Volume 5(2020)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Negative phase 3 randomized controlled trials: Why cancer drugs fail the last barrier?. Issue 8 (26th July 2018) Authors: Gyawali, Bishal; Addeo, Alfredo Journal: International journal of cancer Issue: Volume 143:Issue 8(2018) Page Start: 2079 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere. (15th April 2020) Authors: Banna, Giuseppe; Curioni-Fontecedro, Alessandra; Friedlaender, Alex; Addeo, Alfredo Journal: ESMO open Issue: Volume 4(2019)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study. (November 2021) Authors: Da Silva Lopes, André Manuel; Colomer-Lahiguera, Sara; Mederos Alfonso, Nuria; Aedo-Lopez, Veronica; Spurrier-Bernard, Gilliosa; Tolstrup, Lærke Kjær; Pappot, Helle; Aspeslagh, Sandrine; Rogiers, Anne; Neyns, Bart; Haanen, John B.; Mitchell, Sandra A.; Addeo, Alfredo; Michielin, Olivier; Eicher, ... Journal: European journal of cancer Issue: Volume 157(2021) Page Start: 225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Reply to Authors. (13th May 2020) Authors: Banna, Giuseppe; Curioni-Fontecedro, Alessandra; Friedlaender, Alex; Addeo, Alfredo Journal: ESMO open Issue: Volume 4(2019)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗